Clovis Oncology, Inc. (NASDAQ:CLVS) Insider Sells 3000 Shares of Stock

Mindy Sparks
January 13, 2018

(NASDAQ:CLVS). Endurant Cap Mgmt LP invested in 56,750 shares or 1.42% of the stock. Volume is the basic fuel of the market since stocks move up or down in price only when shares are trading hands. About 661,421 shares traded.

Clovis Oncology (NASDAQ:CLVS) last announced its quarterly earnings data on Wednesday, November 1st. It has outperformed by 266.01% the S&P500.

Yhb Investment Advisors Inc decreased its stake in Union Pac Corp (UNP) by 7.84% based on its latest 2017Q3 regulatory filing with the SEC. The Pura Vida Investments Llc holds 40,000 shares with $2.00 million value, up from 30,000 last quarter. Its monthly volatility value of 4.64% and volatility for the week is valued at 4.92%. The company's market cap is $2.46 billion. The stock increased 1.24% or $0.77 during the last trading session, reaching $62.78. About 118,345 shares traded. (NYSE:AIG) has risen 8.59% since January 12, 2017 and is uptrending.

Among 7 analysts covering Golden Ocean Group (NASDAQ:GOGL), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 70% are positive.

Clovis Oncology Inc (CLVS) now has a 14-day Commodity Channel Index (CCI) of -166.46. (NASDAQ:CLVS) is a good way of gaining insight into the stock's performance. The rating was maintained by Cowen & Co on Friday, August 25 with "Hold".

Taking a deeper look into the technical levels of Clovis Oncology Inc (CLVS), we can see that the Williams Percent Range or 14 day Williams %R now sits at -89.49. The stock of General Electric Company (NYSE:GE) earned "Outperform" rating by RBC Capital Markets on Monday, November 30. The firm has "Overweight" rating by Piper Jaffray given on Thursday, January 26. The firm has "Buy" rating given on Wednesday, September 21 by Stifel Nicolaus. Raymond James upgraded the shares of BB in report on Monday, December 7 to "Strong Buy" rating. WallachBeth Capital downgraded the shares of CLVS in report on Tuesday, November 17 to "Hold" rating.

If RVOL is less than 1 it is not In Play on this trading day and Investors may decide not to trade it. Procedure growth of 17% came in higher than our 16.2% estimate and the Street's 15.1% forecast. It worsened, as 48 investors sold CLVS shares while 49 reduced holdings. 42 funds opened positions while 98 raised stakes. New England Rech & Mgmt owns 0.54% invested in Union Pacific Corporation (NYSE:UNP) for 6,389 shares. Oppenheimer restated a "hold" rating on shares of Clovis Oncology in a research report on Tuesday, October 10th. Fred Alger Mgmt has invested 0.32% in Clovis Oncology, Inc. Also, Clovis Oncology, Inc.

Analysts await Shire plc (NASDAQ:SHPG) to report earnings on February, 15. Hedeker Wealth Limited Liability holds 71,535 shares or 1.52% of its portfolio. Royal Financial Bank Of Canada holds 82,512 shares. (NASDAQ:CLVS). State Common Retirement Fund reported 0.01% of its portfolio in Clovis Oncology, Inc. Zurcher Kantonalbank (Zurich Cantonalbank) invested 0% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS) or 35,400 shares. Lord Abbett & Ltd Liability Company holds 0.07% of its portfolio in Clovis Oncology, Inc. Bb&T invested in 0% or 3,500 shares. (NASDAQ:CLVS). Natixis accumulated 3,426 shares.

Since August 4, 2017, it had 0 insider buys, and 5 sales for $2.32 million activity. (NASDAQ:CLVS) shares with value of $292,365 were sold by SPICKSCHEN THORLEF. Clovis Oncology had a negative net margin of 947.47% and a negative return on equity of 122.06%. Mizuho initiated it with "Neutral" rating and $69 target in Friday, December 11 report. It also upped Vanguard Reit Etf (VNQ) stake by 8,491 shares and now owns 31,439 shares. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have issued a buy rating to the stock. Therefore 41% are positive. FBR Capital maintained it with "Mkt Perform" rating and $53 target in Tuesday, May 10 report. RBC Capital Markets has "Outperform" rating and $94 target. The stock has "In-Line" rating by Imperial Capital on Friday, October 28. The stock of The Brink's Company (NYSE:BCO) has "Neutral" rating given on Friday, September 16 by Macquarie Research. RBC Capital Markets has "Buy" rating and $73.0 target.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of stock price movements.

Since July 31, 2017, it had 0 buys, and 6 sales for $34.06 million activity. BLAIR JAMES C sold $1.45M worth of stock.

Investors sentiment decreased to 0.69 in Q3 2017. Its up 0.15, from 0.64 in 2017Q2. It increased, as 72 investors sold AIG shares while 293 reduced holdings. 61 funds opened positions while 85 raised stakes. 10,069 are owned by First Manhattan. Moreover, Tocqueville Asset Management Limited Partnership has 0.07% invested in The Brink's Company (NYSE:BCO) for 75,128 shares. 240.32 million shares or 2.88% more from 233.59 million shares in 2017Q2 were reported. (NASDAQ:CLVS). Glg Limited Company reported 0.15% stake. Pnc Fincl Service Gru reported 4,060 shares stake. Macroview Investment Mngmt Ltd Liability Com owns 2 shares. Korea stated it has 793,910 shares. Endurant Management Lp reported 1.42% stake. Fisher Asset Management Ltd has 26,633 shares. Webster Bank N A holds 0.01% or 490 shares. About 2.33M shares traded or 37.10% up from the average.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article